Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Raised to $52.00 at Scotiabank
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its price target lifted by stock analysts at Scotiabank from $51.00 to $52.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “sector outperform” rating on the biotechnology company’s stock. RCKT has been the subject of a number of other reports. Wedbush […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its price target lifted by stock analysts at Scotiabank from $51.00 to $52.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “sector outperform” rating on the biotechnology company’s stock. RCKT has been the subject of a number of other reports. Wedbush […]
